Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat

Psychopharmacology

Volumn 231, Issue 11, 2014, Pages 2349-2360

  Paris, Jason J ^a   Singh, Harminder D ^a   Ganno, Michelle L ^a   Jackson, Pauline ^a   McLaughlin, Jay P ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

GT tg bigenic; HIV associated neurocognitive disorder; Marble burying; NeuroAIDS; Open field; Social interactions; Strain differences; Transactivator of transcription; Transcriptional activator

Indexed keywords

DOXYCYCLINE HYCLATE; TRANSACTIVATOR PROTEIN; DOXYCYCLINE; PSYCHOTROPIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATIONAL STUDY; LOCOMOTION; LONG TERM EXPOSURE; MALE; MARBLE BURYING TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SOCIAL INTERACTION TEST; TASK PERFORMANCE; TREATMENT DURATION; WESTERN BLOTTING; ANIMAL; ANXIETY DISORDER; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; TIME; TRANSGENIC MOUSE;

ANIMALS; ANXIETY DISORDERS; BLOTTING, WESTERN; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; GENE EXPRESSION; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROPSYCHOLOGICAL TESTS; PSYCHOTROPIC DRUGS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TIME FACTORS;

EID: 84900866610     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3385-1     Document Type: Article

References (64)

1. Agbottah E, Zhang N, Dadgar S, Pumfrey A, Wade JD, Zeng C, Kashanchi F (2006) Inhibition of HIV-1 virus replication using small soluble Tat peptides. Virology 345:373-389. doi: 10.1016/j.virol.2005.09.062
2. Albelda N, Joel D (2012) Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates. Neurosci Biobehav Rev 36:47-63. doi: 10.1016/j.neubiorev.2011.04.006
3. Atkinson JH Jr, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA (1988) Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatry 45:859-864. doi: 10.1001/archpsyc.1988.01800330091011
4. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M (2001) Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 58:721-728. doi: 10.1001/archpsyc.58.8.721
5. Bolivar VJ, Walters SR, Phoenix JL (2007) Assessing autism-like behavior in mice: variations in social interactions among inbred strains. Behav Brain Res 176:21-26. doi: 10.1016/j.bbr.2006.09.007
6. Bravo P, Edwards A, Rollnick S, Elwyn G (2010) Tough decisions faced by people living with HIV: a literature review of psychosocial problems. AIDS Rev 12:76-88
7. Brocardo PS, Boehme F, Patten A, Cox A, Gil-Mohapel J, Christie BR (2012) Anxiety- and depression-like behaviors are accompanied by an increase in oxidative stress in a rat model of fetal alcohol spectrum disorders: Protective effects of voluntary physical exercise. Neuropharmacology 62:1607-1618. doi: 10.1016/j.neuropharm.2011.10.006
8. Broekkamp CL, Rijk HW, Joly-Gelouin D, Lloyd KL (1986) Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim- induced grooming in mice. Eur J Pharmacol 126:223-229. doi: 10.1016/0014-2999(86)90051-8
9. Bruce-Keller AJ, Barger SW, Moss NI, Pham JT, Keller JN, Nath A (2001) Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17β-estradiol. J Neurochem 78:1315-1324. doi: 10.1046/j.1471-4159.2001.00511.x
10. Carey AN, Liu X, Mintzopoulos D, Paris JJ, Muschamp JW, McLaughlin JP, Kaufman MJ (2013) Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions. Prog Neuropsychopharmacol Biol Psychiatry 43:49-54. doi: 10.1016/j.pnpbp.2012.12.018
11. Carey AN, Sypek EI, Singh HD, Kaufman MJ, McLaughlin JP (2012) Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res 229:48-56. doi: 10.1016/j.bbr.2011.12.019
12. Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B (1997) HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 11:1421-1431
13. Chang JR, Mukerjee R, Bagashev A, Del Valle L, Chabrashvili T, Hawkins BJ, He JJ, Sawaya BE (2011) HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. J Biol Chem 286:41125-41134. doi: 10.1074/jbc.M111.268466
14. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR, HPTN 052 Study Team (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365:493-505. doi: 10.1056/NEJMoa1105243
15. Deacon RMJ (2009) Digging in mice: marble burying, burrowing, and direct observation reveal changes in mouse behavior. In: Gould TD (ed) Mood and anxiety related phenotypes in mice: characterization using behavioral tests. Humana Press, New York, pp 37-46
16. Desrumaux C, Risold PY, Schroeder H, Deckert V, Masson D, Athias A, Laplanche H, Le Guern N, Blache D, Jiang XC, Tall AR, Desor D, Lagrost L (2005) Phospholipid transfer protein deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J 19:296-297. doi: 10.1096/fj.04-2400fje
17. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84-86. doi: 10.1038/345084a0
18. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67:277-287
19. Fanselow MS, Ponnusamy R (2008) The use of conditioning tasks to model fear and anxiety. In: Banchard RJ, Blanchard C (eds) Handbook of anxiety and fear. Elsevier, the Netherlands, pp 29-48
20. Fendt M, Fanselow MS (1999) The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 23:743-760. doi: 10.1016/S0149- 7634(99)00016-0
21. File SE, Hyde JRG (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19-24
22. Fitting S, Ignatowska-Jankowska BM, Bull C, Skoff RP, Lichtman AH, Wise LE, Fox MA, Su J, Medina AE, Krahe TE, Knapp PE, Guido W, Hauser KF (2013) Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 tat transgenic mice. Biol Psychiatry 73:443-453. doi: 10.1016/j.biopsych.2012.09.026
23. Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, Knapp PE, Hauser KF (2010) Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Am J Pathol 177:1397-1410. doi: 10.2353/ajpath.2010.090945
24. Gormanns P, Mueller NS, Ditzen C, Wolf S, Holsboer F, Turck CW (2011) Phenome-transcriptome correlation unravels anxiety and depression related pathways. J Psychiatr Res 45:973-979. doi: 10.1016/j.jpsychires.2010.12.010
25. Gould TD, Dao DT, Kovacsics CE (2009) The open field test. In: Gould TD (ed) Mood and anxiety related phenotypes in mice: characterization using behavioral tests. Humana Press, New York, pp 1-20
26. Grove M, Plumb M (1993) C/EBP, NF-κB, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1α immediate-early gene. Mol Cell Biol 13:5276-5289. doi: 10.1128/MCB.13.9.5276
27. Hall C, Ballachey EL (1932) A study of the rat's behavior in a field: a contribution to method in comparative psychology. Univ Calif Publ Psychol 6:1-12
28. Haughey NJ, Holden CP, Nath A, Geiger JD (1999) Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J Neurochem 73:1363-1374. doi: 10.1046/j.1471-4159.1999.0731363.x
29. Hoge EA, Brandstetter K, Moshier S, Pollack MH, Wong KK, Simon NM (2009) Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 26:447-455. doi: 10.1002/da.20564
30. Holmes A, Wrenn CC, Harris AP, Thayer KE, Crawley JN (2002) Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav 1:55-69. doi: 10.1046/j.1601-1848. 2001.00005.x
31. Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, Male D, Everall I (2000) Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol 6:145-155. doi: 10.3109/13550280009013159
32. Jansen F, Heiming RS, Lewejohann L, Touma C, Palme R, Schmitt A, Lesch KP, Sachser N (2010) Modulation of behavioural profile and stress response by 5-HTT genotype and social experience in adulthood. Behav Brain Res 207:21-29. doi: 10.1016/j.bbr.2009.09.033
33. Kallnik M, Elvert R, Ehrhardt N, Kissling D, Mahabir E, Welzl G, Faus-Kessler T, de Angelis MH, Wurst W, Schmidt J, Hölter SM (2007) Impact of IVC housing on emotionality and fear learning in male C3HeB/FeJ and C57BL/6J mice. Mamm Genome 18:173-186. doi: 10.1007/s00335-007-9002-z
34. Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ (2003) Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol 162:1693-1707. doi: 10.1016/S0002-9440(10) 64304-0
35. Kruman II, Nath A, Mattson MP (1998) HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154:276-288. doi: 10.1006/exnr.1998.6958
36. Lawson MA, Kelley KW, Dantzer R (2011) Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: A possible mechanism for AIDS comorbid depression. Brain Behav Immun 25:1569-1575. doi: 10.1016/j.bbi.2011.05.006
37. Limoges J, Persidsky Y, Poluektova L, Rasmussen J, Ratanasuwan W, Zelivyanskaya M, McClernon DR, Lanier ER, Gendelman HE (2000) Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice. Neurology 54:379-389
38. Masliah E, DeTeresa RM, Mallory ME, Hansen LA (2000) Changes in Pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14:69-74
39. Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32:57-71. doi: 10.1093/jncimonographs/lgh014
40. Mattson MP, Haughey NJ, Nath A (2005) Cell death in HIV dementia. Cell Death Differ 12:893-904. doi: 10.1038/sj.cdd.4401577
41. Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D, Perno CF (2001) Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci 24:411-416. doi: 10.1016/S0166-2236(00)01819-1
42. Nath A, Conant K, Chen P, Scott C, Major EO (1999) Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 274:17098-17102. doi: 10.1074/jbc.274.24. 17098
43. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47:186-194. doi: 10.1002/1531- 8249(200002)47:2<186::AID-ANA8>3.0.CO;2-3
44. National Research Council (2003) Committee on Guidelines for the Use of Animals in Neuroscience and Behavioral Research. Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. National Academies Press (US), Washington, DC
45. Norman JP, Perry SW, Reynolds HM, Kiebala M, De Mesy Bentley KL, Trejo M, Volsky DJ, Maggirwar SB, Dewhurst S, Masliah E, Gelbard HA (2008) HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS One 3:e3731. doi: 10.1371/journal.pone.0003731
46. Orlando M, Burnam MA, Beckman R, Morton SC, London AS, Bing EG, Fleishman JA (2002) Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res 11:75-82. doi: 10.1002/mpr.125
47. Parada CA, Roeder RG (1999) A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription. EMBO J 18:3688-3701. doi: 10.1093/emboj/18.13.3688
48. Paris JJ, Carey AN, Shay CF, Gomes SM, He JJ, McLaughlin JP (2013) Effects of conditional central expression of HIV-1 Tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice. Neuropsychopharmacology. doi: 10.1038/npp.2013.201
49. Park J, Lee H, Lee Y, Kang YH, Rhim H, Choi SY (2000) Expression of human immunodeficiency virus type 1 Tat proteins in Escherichia coli and application to study Tat functions. J Biochem Mol Biol 33:337-343
50. Poling A, Cleary J, Monaghan M (1981) Burying by rats in response to aversive and nonaversive stimuli. J Exp Anal Behav 35:31-44. doi: 10.1901/jeab.1981.35-31
51. Ralph R, Caine SB (2005) Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J and DBA/2J mice. J Pharmacol Exp Ther 312:733-741. doi: 10.1124/jpet.104.074468
52. + T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice. Transl Psychiatry 3:e280. doi: 10.1038/tp.2013.54
53. Rayne F, Debaisieux S, Bonhoure A, Beaumelle B (2010) HIV-1 Tat is unconventionally secreted through the plasma membrane. Cell Biol Int 34:409-413. doi: 10.1042/CBI20090376
54. Schneider I, Tirsch WS, Faus-Kessler T, Becker L, Kling E, Busse RL, Bender A, Feddersen B, Tritschler J, Fuchs H, Gailus-Durner V, Englmeier KH, de Angelis MH, Klopstock T (2006) Systematic, standardized and comprehensive neurological phenotyping of inbred mice strains in the German Mouse Clinic. J Neurosci Methods 157:82-90. doi: 10.1016/j.jneumeth.2006.04.002
55. Starling I, Wright A, Arbuthnott G, Harkiss G (1999) Acute in vivo neurotoxicity of peptides from Maedi Visna virus transactivating protein Tat. Brain Res 830:285-291. Doi: 10.1016/S0006-8993(99)01407-9
56. Stern Y, Marden K, Bell K, Chen J, Dooneif G, Golsetin S, Mindry D, Richards M, Sano M, Williams J, Gorman J, Ehrhard A, Mayeux R (1991) Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. Arch Gen Psychiatry 48:131-138. doi: 10.1001/archpsyc.1991.01810260039006
57. Tryoen-Tóth P, Chasserot-Golaz S, Tu A, Gherib P, Bader MF, Beaumelle B, Vitale N (2013) HIV-1 Tat protein inhibits neurosecretion by binding to phosphatidylinositol (4,5) bisphosphate. J Cell Sci 126:454-463. doi: 10.1242/jcs.111658
58. Wayman WN, Dodiya HB, Persons AL, Kashanchi F, Kordower JH, Hu XT, Napier TC (2012) Enduring cortical alterations after a single in-vivo treatment of HIV-1 Tat. Neuroreport 23:825-829. doi: 10.1097/WNR.0b013e3283578050
59. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE (1993) Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 33:576-582. doi: 10.1002/ana.410330604
60. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500. doi: 10.1038/375497a0
61. Wiley CA, Baldwin M, Achim CL (1996) Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10:843-947
62. Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19:152-168. doi: 10.1007/s11065-009-9102-5
63. Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT (2000) Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A 97:11466-11471. doi: 10.1073/pnas.97.21.11466
64. Yadav A, Fitzgerald P, Sajadi MM, Gilliam B, Lafferty MK, Redfield R, Reid W (2009) Increased expression of suppressor of cytokine signaling-1 (SOCS-1): A mechanism for dysregulated T helper-1 responses in HIV-1 disease. Virology 385:126-133. doi: 10.1016/j.virol.2008.11.039